Dermapharm Holding SE (DMPHF)
47.69
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Dermapharm Total Assets (Quarterly) : 2.564B for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.564B |
| March 31, 2026 | 2.619B |
| December 31, 2025 | 2.589B |
| September 30, 2025 | 2.488B |
| June 30, 2025 | 2.507B |
| March 31, 2025 | 2.281B |
| December 31, 2024 | 2.175B |
| September 30, 2024 | 2.369B |
| June 30, 2024 | 2.365B |
| March 31, 2024 | 2.347B |
| December 31, 2023 | 2.412B |
| September 30, 2023 | 2.286B |
| June 30, 2023 | 2.306B |
| March 31, 2023 | 2.355B |
| December 31, 2022 | 1.508B |
| September 30, 2022 | 1.422B |
| June 30, 2022 | 1.481B |
| March 31, 2022 | 1.626B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.600B |
| September 30, 2021 | 1.554B |
| June 30, 2021 | 1.515B |
| March 31, 2021 | 1.501B |
| December 31, 2020 | 1.498B |
| September 30, 2020 | 1.432B |
| June 30, 2020 | 1.350B |
| March 31, 2020 | 1.194B |
| December 31, 2019 | 1.173B |
| September 30, 2019 | 1.107B |
| June 30, 2019 | 1.094B |
| March 31, 2019 | 1.080B |
| December 31, 2018 | 805.44M |
| September 30, 2018 | 803.01M |
| June 30, 2018 | 803.74M |
| March 31, 2018 | 835.58M |
| December 31, 2017 | 498.70M |
| September 30, 2017 | 506.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 114.02B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Avadel Pharmaceuticals Plc | 199.45M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.954B |
| Shareholders Equity (Quarterly) | 613.63M |
| Debt to Equity Ratio | 2.178 |
| Current Ratio | 1.712 |
| Net Debt Paydown Yield | -1.99% |